Related Experiment Videos

Fungal keratitis: emerging trends and treatment outcomes

Sandhya A Iyer1, Sonal S Tuli, Ryan C Wagoner

  • 1Department of Ophthalmology, University of Florida, Gainesville, FL, USA. stuli@ufl.edu

Eye & Contact Lens
|November 14, 2006
PubMed
Abstract

Insights

Contact lens wear is an increasing risk factor for fungal keratitis. Aggressive dual topical antifungal therapy can lead to good visual outcomes in patients with fungal keratitis.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Fungal keratitis is a serious ocular infection that can lead to vision loss.
  • Identifying trends and risk factors is crucial for effective prevention and treatment.

Purpose of the Study:

  • To review trends, risk factors, causative organisms, treatment, and outcomes of fungal keratitis.
  • To analyze changes in risk factors over time, particularly the role of contact lens use.

Main Methods:

  • Retrospective review of fungal keratitis cases from January 1999 to June 2006.
  • Analysis of patient demographics, risk factors, microbial isolates, treatment strategies, and visual outcomes.

Main Results:

  • Contact lens use surpassed trauma as the leading risk factor for fungal keratitis after 2005.
  • Fusarium species were the most common isolates, with increasing incidence of non-therapeutic contact lens-related infections.
  • 56% of patients presented with visual acuity worse than 20/200; 70% achieved 20/40 or better with medication alone.

Conclusions:

  • Contact lens wear is a significant and growing risk factor for fungal keratitis.
  • Early and aggressive dual topical antifungal therapy is associated with favorable visual outcomes.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...